Jade Teakell

November 4, 2024

Background

FLOZINATing to the Future- Long Term Effects of Empagliflozin in Patients with CKD

Jade Teakell

November 4, 2024

Background

FLOZINATing to the Future- Long Term Effects of Empagliflozin in Patients with CKD

This week, we will discuss post-trial follow-up for EMPA-Kidney. What are the longer-term effects of empagliflozin for patients with chronic kidney disease?

Jade Teakell

September 10, 2024

Background

The pressure is on! Unravelling the ESPRIT of Intensive vs Standard BP Control

Jade Teakell

September 10, 2024

Background

The pressure is on! Unravelling the ESPRIT of Intensive vs Standard BP Control

This week, we will discuss the ongoing saga of blood pressure targets in patients with hypertension. This time its ESPRIT (Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing Risk of Vascular Events) making a case for case for intensive BP control in most hypertensive individuals, including those with a history of diabetes and stroke.

Jade Teakell

April 22, 2024

Background

Shedding Light on the Dense Matter of C3 Glomerulopathy

Jade Teakell

April 22, 2024

Background

Shedding Light on the Dense Matter of C3 Glomerulopathy

This week, we will discuss the role of ApoE in determining the subtypes of C3 Glomerulopathy.

Jade Teakell

October 11, 2023

Commentary, news, Meta

NOSTONE in Kidney Medicine

Jade Teakell

October 11, 2023

Commentary, news, Meta

Our NephJC NOSTONE editorial in Kidney Medicine is live. Great work from Renz Palisan, Nikita Pawar, and Rasha Alawieh; supported by Swap and Jade.

Read it here.

Jade Teakell

October 3, 2023

Background

Salt-N-Water: PUSH it real good

Jade Teakell

October 3, 2023

Background

This week on NephJC we are hashing out the Pragmatic Urinary Sodium-based treatment algoritHm in Acute Heart Failure (PUSH-AHF) trial!

Jade Teakell

August 21, 2023

Background

CXCL9: A Urinary Marker ExplAINed

Jade Teakell

August 21, 2023

Background

What do you do when you suspect AIN (and eosinophils aren’t helpful) and you can’t get a kidney biopsy? CXCL9 is a newly discovered urinary marker that may help in the diagnosis of AIN. This week we will discuss the process of isolating and utilizing this new diagnostic test.

Jade Teakell

June 5, 2023

Background

A litmus test: Does Sodium Bicarbonate Prevent Graft Function Decline?

Jade Teakell

June 5, 2023

Background

A litmus test: Does Sodium Bicarbonate Prevent Graft Function Decline?

This week, we will discuss the effects of oral bicarbonate therapy in kidney transplant recipients.
Preserve-Transplant Study from Lancet.

Jade Teakell

February 28, 2023

Background

Vacillation in Atrial Fibrillation on Hemodialysis Continues

Jade Teakell

February 28, 2023

Background

Vacillation in Atrial Fibrillation on Hemodialysis Continues

This week, we will discuss the a small step forward in understanding the role of anticoagulation in atrial fibrillation in ESRD.

Jade Teakell

October 25, 2022

Background

Is the horse before the CAR T in SLE?

Jade Teakell

October 25, 2022

Background

CAR T cells now in nephrology. And where to begin if not in the vexing issue of refractory lupus nephritis.

Jade Teakell

May 23, 2022

Background

A New CHAPter in an Old Story

Jade Teakell

May 23, 2022

Background

This week, we have a practice changing study about the treatment of mild hypertension during pregnancy. Join us on Tuesday (9 EDT) and Wednesday (9 IST).

Jade Teakell

April 19, 2022

Background

ISPD Peritonitis Update 2022

Jade Teakell

April 19, 2022

Background

We have a long awaited huge update on the ISPD peritonitis guidelines. Bugs change and we need to change how we treat them. We break down the evidence for you in this summary

Jade Teakell

March 21, 2022

Background

Diuretic Resistance in Heart Failure

Jade Teakell

March 21, 2022

Background

This week we discuss the mechanistic study looking at diuretic resistance. Timed with the NephMadness cardiorenal region!